BlackRock Health Sciences Term Trust (NYSE:BMEZ) Announces Monthly Dividend of $0.18

BlackRock Health Sciences Term Trust (NYSE:BMEZ) declared a monthly dividend on Thursday, September 12th, NASDAQ reports. Stockholders of record on Tuesday, October 15th will be paid a dividend of 0.176 per share on Thursday, October 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.37%. The ex-dividend date is Tuesday, October 15th.

BlackRock Health Sciences Term Trust has raised its dividend payment by an average of 20.7% per year over the last three years.

BlackRock Health Sciences Term Trust Trading Up 0.5 %

Shares of BlackRock Health Sciences Term Trust stock traded up 0.08 on Friday, reaching 15.79. 170,600 shares of the stock were exchanged, compared to its average volume of 271,406. The business has a 50 day moving average price of 15.85 and a two-hundred day moving average price of 15.50. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 16.59.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. bought 1,633 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Friday, September 27th. The stock was purchased at an average price of 15.89 per share, with a total value of 25,948.37. Following the completion of the acquisition, the insider now directly owns 20,653,378 shares in the company, valued at approximately 328,182,176.42. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders acquired 54,554 shares of company stock worth $871,545.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.